Related Articles 2016 AAHA/IAAHPC End-of-Life Care Guidelines. J Am Anim Hosp Assoc. 2016 Nov/Dec;52(6):341-356 Authors: Bishop G, Cooney K, Cox S, Downing R, Mitchener K, Shanan A, Soares N, Stevens B, Wynn T Abstract End-of-life (EOL) care and decisionmaking embody the critical final stage in a pet’s life and are as important and meaningful as the sum of the clinical care provided for all prior life stages. EOL care should focus on maximizing patient comfort and minimizing suffering while providing a collaborative and supportive partnership with the caregiver client. Timely, empathetic, and nonjudgmental communication is the hallmark of effective client…
Origen: 2016 AAHA/IAAHPC End-of-Life Care Guidelines. – PubMed

Related Articles [Screening for Pain in Cancer Patients]. Gan To Kagaku Ryoho. 2016 Oct;43(10):1141-1148 Authors: Matoba M Abstract The newly revised 2014 Set of Standards for»Designated Cancer Care Hospitals»mandated the screening of all cancer patients6 for their physical and psychological suffering systematically in both outpatient and inpatient settings as well as rapid response to the suffering detected. It is a step forward as a cancer control policy, but because the pain associated with cancer changes by time depending on factors such as disease progression and treatment, it must be evaluated repeatedly. Simply complying with the standard by measuring once, say…
Origen: [Screening for Pain in Cancer Patients]. – PubMed

Related Articles Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? Oncology. 2017;92(1):1-2 Authors: Markman M PMID: 27923224 [PubMed – indexed for MEDLINE]
Origen: Why Should Phase 1 Cancer Trial Participation and Optimal End-of-Life Care Be Incompatible? – PubMed

Related Articles Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. Anticancer Res. 2017 01;37(1):203-206 Authors: Rades D, Bolm L, Schild SE, Bartscht T Abstract AIM: The goal of this study was to identify prognostic factors of survival in patients receiving palliative external-beam radiotherapy (EBRT) for advanced liver cancer. PATIENTS AND METHODS: Seventeen patients irradiated for advanced liver cancer were retrospectively evaluated. Fourteen patients had metastatic disease, three had locally advanced disease. Six variables were investigated for survival: age at EBRT, time from liver cancer diagnosis to EBRT, number of involved metastatic sites, gender, Eastern Cooperative Oncology…
Origen: Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer. – PubMed

Related Articles Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer. Anticancer Res. 2017 01;37(1):267-275 Authors: Okugawa Y, Shirai Y, Nodono H, Matsutani F, Itoh M, Hishida A, Morimoto Y, Nishikawa R, Yokoe T, Tanaka K, Urata H, Toiyama Y, Araki T, Inoue Y, Tanaka M, Kusunoki M, Miki C Abstract BACKGROUND: In palliative care, prediction of life expectancy is one of the most crucial issues for patients, family and medical staff, in order to provide appropriate end-of-life care. The aim of this study was to formulate a new objective score to predict…
Origen: Objective Predictive Score as a Feasible Biomarker for Short-term Survival in TerminalIy Ill Patients with Cancer. – PubMed